Genomically guided cancer treatments: from "promising" to "clinically useful"

Affiliations

¹ Division of Cancer Treatment and Diagnosism, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, 9609 Medical Center Drive Room 4W426 MSC 9730, Bethesda, MD, 20892 conleyba@mail.nih.gov.

Editorial

Barbara A Conley. J Natl Cancer Inst. 2015.

. 2015 May 28;107(7):djv168.

doi: 10.1093/jnci/djv168. Print 2015 Jul.

¹ Division of Cancer Treatment and Diagnosism, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, 9609 Medical Center Drive Room 4W426 MSC 9730, Bethesda, MD, 20892 conleyba@mail.nih.gov.

No abstract available

Comment on

A decision support framework for genomically informed investigational cancer therapy.
Meric-Bernstam F, Johnson A, Holla V, Bailey AM, Brusco L, Chen K, Routbort M, Patel KP, Zeng J, Kopetz S, Davies MA, Piha-Paul SA, Hong DS, Eterovic AK, Tsimberidou AM, Broaddus R, Bernstam EV, Shaw KR, Mendelsohn J, Mills GB. Meric-Bernstam F, et al. J Natl Cancer Inst. 2015 Apr 11;107(7):djv098. doi: 10.1093/jnci/djv098. Print 2015 Jul. J Natl Cancer Inst. 2015. PMID: 25863335 Free PMC article. Review.